Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthopediatrics (KIDS) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Orthopediatrics (KIDS) over the last 10 years, with Q3 2025 value amounting to $5.3 million.

  • Orthopediatrics' Depreciation & Amortization (CF) rose 35.98% to $5.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.5 million, marking a year-over-year decrease of 376.84%. This contributed to the annual value of $19.1 million for FY2024, which is 974.98% up from last year.
  • As of Q3 2025, Orthopediatrics' Depreciation & Amortization (CF) stood at $5.3 million, which was up 35.98% from $5.2 million recorded in Q2 2025.
  • Orthopediatrics' Depreciation & Amortization (CF)'s 5-year high stood at $5.3 million during Q3 2025, with a 5-year trough of $2.5 million in Q1 2021.
  • Its 5-year average for Depreciation & Amortization (CF) is $4.0 million, with a median of $4.0 million in 2024.
  • As far as peak fluctuations go, Orthopediatrics' Depreciation & Amortization (CF) skyrocketed by 8465.45% in 2021, and later plummeted by 2301.91% in 2024.
  • Orthopediatrics' Depreciation & Amortization (CF) (Quarter) stood at $2.8 million in 2021, then rose by 25.27% to $3.5 million in 2022, then surged by 47.36% to $5.2 million in 2023, then decreased by 23.02% to $4.0 million in 2024, then skyrocketed by 32.71% to $5.3 million in 2025.
  • Its Depreciation & Amortization (CF) stands at $5.3 million for Q3 2025, versus $5.2 million for Q2 2025 and $5.0 million for Q1 2025.